EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Local Antibiotic Delivery Options in Prosthetic Joint Infection

William Steadman iD, Paul R Chapman iD, Michael Schuetz, Beat Schmutz, Andrej Trampuz iD, Kevin Tetsworth

Antibiotics · 14.04.2023 · 12 (4) · 752

DOI: 10.3390/antibiotics12040752 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 14.04.2023. Verfasst von William Steadman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Jamieson Trauma Institute, Royal Brisbane and Women's Hospital, Herston, Brisbane 4029, Australia. Die Arbeit wurde bisher 89-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prosthetic Joint Infection (PJI) causes significant morbidity and mortality for patients globally. Delivery of antibiotics to the site of infection has potential to improve the treatment outcomes and enhance biofilm eradication. These antibiotics can be delivered using an intra-articular catheter or combined with a carrier substance to enhance pharmacokinetic properties. Carrier options include non-resorbable polymethylmethacrylate (PMMA) bone cement and resorbable calcium sulphate, hydroxyapatite, bioactive glass, and hydrogels. PMMA allows for creation of structural spacers used in multi-stage revision procedures, however it requires subsequent removal and antibiotic compatibility and the levels delivered are variable. Calcium sulphate is the most researched resorbable carrier in PJI, but is associated with wound leakage and hypercalcaemia, and clinical evidence for its effectiveness remains at the early stage. Hydrogels provide a versatile combability with antibiotics and adjustable elution profiles, but clinical usage is currently limited. Novel anti-biofilm therapies include bacteriophages which have been used successfully in small case series.

Schlagwörter

Stichwörter der Autor:innen

DAIRantibiotics and implant retentionbacteriophagesbioactive glasscalcium phosphatecalcium sulphatedebridementexchange arthroplastyhydrogellocal antibioticsorthopaedic device related infectionprosthetic joint infectionrevision arthroplasty

Autor:innen und Institutionen

  • Jamieson Trauma Institute, Royal Brisbane and Women's Hospital, Herston, Brisbane 4029, Australia.
  • Department of Orthopaedics, Royal Brisbane and Women's Hospital, Herston, Brisbane 4029, Australia.
  • Faculty of Health, Queensland University of Technology, Brisbane 4059, Australia.
  • Herston Infectious Disease Institute, Royal Brisbane and Women's Hospital, Herston, Brisbane 4029, Australia.
  • Department of Infectious Diseases, Royal Brisbane and Women's Hospital, Herston, Brisbane 4029, Australia.
  • School of Mechanical, Medical and Process Engineering, Faculty of Engineering, Queensland University of Technology, Brisbane 4000, Australia.

ORCID-Profile: William Steadman, Paul R Chapman, Andrej Trampuz

Zitieren

APA

Steadman, W., Chapman, P. R., Schuetz, M., Schmutz, B., Trampuz, A., & Tetsworth, K. (2023). Local Antibiotic Delivery Options in Prosthetic Joint Infection. Antibiotics, 12(4), 752. https://doi.org/10.3390/antibiotics12040752

Vancouver

Steadman W, Chapman PR, Schuetz M, Schmutz B, Trampuz A, Tetsworth K. Local Antibiotic Delivery Options in Prosthetic Joint Infection. Antibiotics. 2023;12(4):752. doi:10.3390/antibiotics12040752

BibTeX
@article{Steadman2023,
  author = {Steadman, William and Chapman, Paul R and Schuetz, Michael and Schmutz, Beat and Trampuz, Andrej and Tetsworth, Kevin},
  title = {Local Antibiotic Delivery Options in Prosthetic Joint Infection},
  journal = {Antibiotics},
  year = {2023},
  volume = {12},
  number = {4},
  pages = {752},
  doi = {10.3390/antibiotics12040752}
}
Kostenlos starten →